Such a scenario is validated by previous research identifying heightened CEMIP expression in the chondrocytes and synovial fibroblasts of osteoarthritis patients, implicating it as a driver of HA degradation and associated pathophysiological changes.44, 45. This evidence concerns the gene CEMIP and osteoarthritis.